Caribou Biosciences, Inc. (NASDAQ:CRBU) has 120 institutional investors with active 13F positions as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Pfizer Inc | 31 Dec, 2025 | 4,690,431 | 0 | 0.00% | $7,457,785.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 4,304,198 | 77,272 | 1.83% | $6,843,676.00 |
| Kynam Capital Management, LP | 31 Dec, 2025 | 2,503,302 | -564,472 | -18.40% | $3,980,250.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 2,141,023 | 681,703 | 46.71% | $3,404,227.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 1,639,857 | 859,436 | 110.12% | $2,607,373.00 |
| Aberdeen Group plc | 31 Dec, 2025 | 1,388,905 | 0 | 0.00% | $2,208,359.00 |
| TWO SIGMA ADVISERS, LP | 31 Dec, 2025 | 1,115,700 | -111,700 | -9.10% | $1,773,963.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31 Dec, 2025 | 1,031,375 | 585,768 | 131.45% | $1,639,887.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 1,020,079 | 236,489 | 30.18% | $1,621,926.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Dec, 2025 | 1,006,010 | -204,300 | -16.88% | $1,599,556.00 |
| Bank Of America Corp /De/ | 31 Dec, 2025 | 993,186 | -1,155,698 | -53.78% | $1,579,166.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 978,276 | 733,452 | 299.58% | $1,555,460.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 976,813 | -8,313 | -0.84% | $1,553,785.00 |
| PFM Health Sciences, LP | 31 Dec, 2025 | 957,787 | -401,044 | -29.51% | $1,522,881.00 |
| MARSHALL WACE, LLP | 31 Dec, 2025 | 881,105 | 755,261 | 600.16% | $1,400,957.00 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 31 Dec, 2025 | 824,299 | 475,216 | 136.13% | $1,310,635.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Dec, 2025 | 767,002 | -2,449,533 | -76.15% | $1,219,533.00 |
| FMR LLC | 31 Dec, 2025 | 725,968 | -3,034 | -0.42% | $1,154,289.00 |
| MAVERICK CAPITAL LTD | 31 Dec, 2025 | 652,542 | 0 | 0.00% | $1,037,542.00 |
| UBS Group AG | 31 Dec, 2025 | 637,745 | 318,453 | 99.74% | $1,014,015.00 |